Assent Lifetech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 28-06-2024
- Paid Up Capital ₹ 0.38 M
as on 28-06-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 24.40%
(FY 2020)
- Profit -25.19%
(FY 2020)
- Ebitda 352.51%
(FY 2020)
- Net Worth 16.61%
(FY 2020)
- Total Assets 8.12%
(FY 2020)
About Assent Lifetech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.38 M, as per Ministry of Corporate Affairs (MCA) records.
Sangita Devi and Krishna Maharaj serve as directors at the Company.
- CIN/LLPIN
U24232BR2013PTC019857
- Company No.
019857
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Darbhanga, Bihar, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Assent Lifetech Private Limited offer?
Assent Lifetech Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Brain & Nervous System Drugs, Psychotherapeutic Agents, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Antiseptic Mouthwashes, Eye Drops, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Assent Lifetech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sangita Devi  | Director | 08-Apr-2015 | Current |
| Krishna Maharaj | Director | 15-Feb-2013 | Current |
Financial Performance of Assent Lifetech.
Assent Lifetech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 24.4% increase. The company also saw a substantial fall in profitability, with a 25.19% decrease in profit. The company's net worth Soared by an impressive increase of 16.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assent Lifetech?
In 2019, Assent Lifetech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Assent Lifetech?
Unlock and access historical data on people associated with Assent Lifetech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assent Lifetech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assent Lifetech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
